Eyepoint Pharmaceuticals (NASDAQ:EYPT) outlined late-stage clinical progress for its lead retinal candidate DURAVYU and ...
Thank you, and thank you all for joining us on today's conference call to discuss EyePoint Pharmaceuticals, Inc.'s Fourth Quarter and Full Year 2025 financial results and recent corporate developments ...
The Honors Program at School of Visual Arts is a challenging program for artists who seek academic enrichment along with their studio practice. The Honors Program enhances the dual abilities of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results